spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  {prev}
EVENTS FOR 2017
{next}  
   
 
EVENTS FOR PMPS
 
     


There is currently no events listed for this month. Please check all events or come back soon as it is updated regularly.

spacer
Industry Events

Temperature Controlled Logistics in Biopharmaceuticals USA 2018

24-25 April 2018, Princeton, USA

After an extremely successful first edition, Temperature Controlled Logistics in Biopharmaceuticals is back in Princeton in April 2018!
More info >>

Banner of Clinical_Trial_New_England_events_95 on Samedan

Banner of BIO_Europe_Events_102 on Samedan
White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>


News and Press Releases

Prometic Bioseparations are very pleased to introduce their new purpose built ecommerce platform (Webshop)!

Their goal was to build a platform that is easy to navigate, informative and one that makes their products and services easily accessible to researchers and laboratories worldwide. They also wanted to make ordering as quick and easy as possible to meet the needs of the rapidly progressive industry. They have reflected these requirements with an ecommerce store in order to supply high quality products to customers from academia to big pharma.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement